TOKYO, February 13, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) would like to express its deepest sympathy to victims of the earthquake in Turkey and Syria.
Astellas has pledged a donation as follows to support the victims and to assist in reconstruction efforts.
Contributor: Astellas Pharma Inc.
Donation to: Japanese Red Cross Society
Amount: JPY10,000,000
Astellas hopes for the earliest possible recovery in the affected areas.
Click below for a copy of the full press release
